NSE · PARNAXLAB
Parnax Lab Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#2,715
of 5,004 stocks
▼ 531W
Peak #2,662 · 21 Sep 2026
A microcap name in Healthcare, Parnax Lab Limited trades at an undemanding earnings multiple, is growing revenue rapidly, and remains firmly promoter-controlled, with promoters holding 72%.
Market Cap
128.33 Cr
P/E Ratio
10.88
P/B Ratio
1.35
ROE
12.38%
ROCE
17.44%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 56.80 Cr | 69.63 Cr | 62.94 Cr | 62.60 Cr |
| Net Profit | 42.50 L | 2.18 Cr | 2.72 Cr | 3.62 Cr |
| EPS | 0.37 | 1.90 | 2.37 | 3.15 |
| Operating Profit | 2.24 Cr | 4.84 Cr | 5.86 Cr | 6.61 Cr |
Shareholding pattern
Promoter
72.30%
Public
27.70%
PUBLIC BREAKDOWN
Individuals
23.63%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
No corporate actions on record for this stock.
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.